Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 01/31/14
Due: 01/31/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy | NCT01472510 | Vitreo-Retinal Associates, PC | user2@example.com | None | 2011-12-31 | 2014-01-31 | 2015-01-31 | - | - | 2025-07-14 |